A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Surmodics Inc stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 57,627 shares of SRDX stock, worth $1.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
57,627
Previous 50,348 14.46%
Holding current value
$1.69 Million
Previous $1.95 Million 16.91%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$37.5 - $40.13 $272,962 - $292,106
7,279 Added 14.46%
57,627 $2.28 Million
Q3 2024

Nov 07, 2024

BUY
$38.47 - $42.24 $1.94 Million - $2.13 Million
50,348 New
50,348 $1.95 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $411M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.